loadpatents
Patent applications and USPTO patent grants for Pavco; Pamela A..The latest application filed is for "rna interference in dermal and fibrotic indications".
Patent | Date |
---|---|
Rna Interference In Dermal And Fibrotic Indications App 20210261968 - Khvorova; Anastasia ;   et al. | 2021-08-26 |
Nucleic acid molecules targeting superoxide dismutase 1 (SOD1) Grant 11,001,845 - Cardia , et al. May 11, 2 | 2021-05-11 |
Rna Interference In Ocular Indications App 20210062195 - Libertine; Lyn ;   et al. | 2021-03-04 |
RNA interference in dermal and fibrotic indications Grant 10,913,948 - Khvorova , et al. February 9, 2 | 2021-02-09 |
RNA interference in skin indications Grant 10,815,485 - Khvorova , et al. October 27, 2 | 2020-10-27 |
RNA interference in ocular indications Grant 10,662,430 - Libertine , et al. | 2020-05-26 |
Modified RNAi polynucleotides and uses thereof Grant 10,633,654 - Pavco , et al. | 2020-04-28 |
Rna Interference In Ocular Indications App 20190233826 - Libertine; Lyn ;   et al. | 2019-08-01 |
Modified Rnai Polynucleotides And Uses Thereof App 20190169608 - Pavco; Pamela A. ;   et al. | 2019-06-06 |
RNA interference in ocular indications Grant 10,184,124 - Libertine , et al. Ja | 2019-01-22 |
Rna Interference In Dermal And Fibrotic Indications App 20180371464 - Khvorova; Anastasia ;   et al. | 2018-12-27 |
Modified RNAi polynucleotides and uses thereof Grant 10,131,904 - Pavco , et al. November 20, 2 | 2018-11-20 |
Rna Interference In Skin Indications App 20180327748 - Khvorova; Anastasia ;   et al. | 2018-11-15 |
Nucleic Acid Molecules Targeting Superoxide Dismutase 1 (sod1) App 20180195072 - Cardia; James ;   et al. | 2018-07-12 |
RNA interference in dermal and fibrotic indications Grant 9,963,702 - Khvorova , et al. May 8, 2 | 2018-05-08 |
RNA interference in skin indications Grant 9,938,530 - Khvorova , et al. April 10, 2 | 2018-04-10 |
Rna Interference In Dermal And Fibrotic Indications App 20170067056 - Khvorova; Anastasia ;   et al. | 2017-03-09 |
Methods For Treatment Of Disorders In The Front Of The Eye Utilizing Nucleic Acid Molecules App 20170051290 - Byrne; Michael ;   et al. | 2017-02-23 |
Rna Interference In Skin Indications App 20170009239 - Khvorova; Anastasia ;   et al. | 2017-01-12 |
Methods For Treatment Of Wound Healing Utilizing Chemically Modified Oligonucleotides App 20160304875 - Cauwenbergh; Gerard ;   et al. | 2016-10-20 |
RNA interference in dermal and fibrotic indications Grant 9,340,786 - Khvorova , et al. May 17, 2 | 2016-05-17 |
Rna Interference In Ocular Indications App 20160115482 - Libertine; Lyn ;   et al. | 2016-04-28 |
RNA interference in skin indications Grant 9,303,259 - Khvorova , et al. April 5, 2 | 2016-04-05 |
Rna Interference In Skin Indications App 20140315974 - KHVOROVA; ANASTASIA ;   et al. | 2014-10-23 |
Interference In Dermal And Fibrotic Indications App 20140113950 - Khvorova; Anastasia ;   et al. | 2014-04-24 |
RNA interference in skin indications Grant 8,664,189 - Khvorova , et al. March 4, 2 | 2014-03-04 |
Rnai Constructs And Uses Thereof App 20110251258 - Samarsky; Dmitry ;   et al. | 2011-10-13 |
Rna Interference In Skin Indications App 20110237648 - Khvorova; Anastasia ;   et al. | 2011-09-29 |
Modified Rnai Polynucleotides And Uses Thereof App 20110039914 - Pavco; Pamela A. ;   et al. | 2011-02-17 |
Tripartite RNAi constructs App 20090131360 - Woolf; Tod M. ;   et al. | 2009-05-21 |
Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection App 20030171311 - Blatt, Lawrence ;   et al. | 2003-09-11 |
Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection App 20030125270 - Blatt, Lawrence ;   et al. | 2003-07-03 |
Enzymatic Nucleic Acid Treatment Of Diseases Or Conditions Related To Hepatitis C Virus Infection App 20020082225 - BLATT, LAWRENCE ;   et al. | 2002-06-27 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.